Evidence map›Paper›PMID 35994701›Full record

ArticleRadiation research2023

Validation of a High-Throughput Dicentric Chromosome Assay Using Complex Radiation Exposures.

Ekaterina Royba, Mikhail Repin, Adayabalam S Balajee, Igor Shuryak, Sergey Pampou, Charles Karan, Yi-Fang Wang, Olga Dona Lemus, Razib Obaid, Naresh Deoli and 3 more

Abstract read
In one paragraph

Article in Radiation research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Co-occurrence of acrocentric chromosome associations with dicentric chromosomes in irradiated human lymphocytes.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2023
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ekaterina RoybaCenter for Radiological Research, Columbia University Irving Medical Center, New York, New York.
Mikhail RepinCenter for Radiological Research, Columbia University Irving Medical Center, New York, New York.
Adayabalam S BalajeeRadiation Emergency Assistance Center/ Training Site (REAC/TS), Cytogenetic Biodosimetry Laboratory (CBL), Oak Ridge Institute for Science and Education, Oak Ridge Associated Universities, Oak Ridge, Tennessee.
Igor ShuryakCenter for Radiological Research, Columbia University Irving Medical Center, New York, New York.
Sergey PampouColumbia Genome Center High-Throughput Screening facility, Columbia University Irving Medical Center, New York, New York.
Charles KaranColumbia Genome Center High-Throughput Screening facility, Columbia University Irving Medical Center, New York, New York.
Yi-Fang WangDepartment of Radiation Oncology, Columbia University Irving Medical Center, New York, New York.
Olga Dona LemusDepartment of Radiation Oncology, Columbia University Irving Medical Center, New York, New York.
Razib ObaidRadiological Research Accelerator facility, Columbia University Irving Medical Center, Irvington, New York.
Naresh DeoliRadiological Research Accelerator facility, Columbia University Irving Medical Center, Irvington, New York.
Cheng-Shie WuuDepartment of Radiation Oncology, Columbia University Irving Medical Center, New York, New York.
David J BrennerCenter for Radiological Research, Columbia University Irving Medical Center, New York, New York.
Guy GartyCenter for Radiological Research, Columbia University Irving Medical Center, New York, New York.

Funding

Sample Engineering CoreU19AI067773 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI FORNACE, ALBERT J · 2005 to 2024
$105.4M
NIAID NIH HHS HHSN272201600040CNIAID NIH HHS U19 AI067773
6 · The paper itself

Abstract

Validation of biodosimetry assays is routinely performed using primarily orthovoltage irradiators at a conventional dose rate of approximately 1 Gy/min. However, incidental/ accidental exposures caused by nuclear weapons can be more complex. The aim of this work was to simulate the DNA damage effects mimicking those caused by the detonation of a several kilotons improvised nuclear device (IND). For this, we modeled complex exposures to: 1. a mixed (photons + IND-neutrons) field and 2. different dose rates that may come from the blast, nuclear fallout, or ground deposition of radionuclides (ground shine). Additionally, we assessed whether myeloid cytokines affect the precision of radiation dose estimation by modulating the frequency of dicentric chromosomes. To mimic different exposure scenarios, several irradiation systems were used. In a mixed field study, human blood samples were exposed to a photon field enriched with neutrons (ranging from 10% to 37%) from a source that mimics Hiroshima's A-bomb's energy spectrum (0.2-9 MeV). Using statistical analysis, we assessed whether photons and neutrons act in an additive or synergistic way to form dicentrics. For the dose rates study, human blood was exposed to photons or electrons at dose rates ranging from low (where the dose was spread over 32 h) to extremely high (where the dose was delivered in a fraction of a microsecond). Potential effects of cytokine treatment on biodosimetry dose predictions were analyzed in irradiated blood subjected to Neupogen or Neulasta for 24 or 48 h at the concentration recommended to forestall manifestation of an acute radiation syndrome in bomb survivors. All measurements were performed using a robotic station, the Rapid Automated Biodosimetry Tool II, programmed to culture lymphocytes and score dicentrics in multiwell plates (the RABiT-II DCA). In agreement with classical concepts of radiation biology, the RABiT-II DCA calibration curves suggested that the frequency of dicentrics depends on the type of radiation and is modulated by changes in the dose rate. The resulting dose-response curves suggested an intermediate dicentric yields and additive effects of photons and IND-neutrons in the mixed field. At ultra-high dose rate (600 Gy/s), affected lymphocytes exhibited significantly fewer dicentrics (P < 0.004, t test). In contrast, we did not find the dose-response modification effects of radiomitigators on the yields of dicentrics (Bonferroni corrected P > 0.006, ANOVA test). This result suggests no bias in the dose predictions should be expected after emergency cytokine treatment initiated up to 48 h prior to blood collection for dicentric analysis.

Indexed as

Chromosome AberrationsRadiation ExposureChromosomesDose-Response Relationship, RadiationHumansLymphocytesRadiometry

Identifiers

PMID35994701
PMCPMC9947868

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.